Overview
A challenge for many health tech startups is pricing their products with a multitude of payers insurance companies, governments, and hospital systems in mind.
How do you get your product reimbursed by insurance companies? How do hospital systems evaluate technology costs, particularly as health systems move toward value-based care models? How are digital health costs integrated into client business models? What is the role of health technology assessment in driving reimbursement rates?
Learn from industry experts to inform your reimbursement strategy of health technologies, from a proof of concept to an established product.
Date: 13 March 2019
Time: 5:30pm 7:30pm
Venue: 32 Carpenter Street, Singapore 059911
Programme:
5:30pm 6:00pm: Registration
6:00pm 7:00pm: Panel Discussion and Q&A
- Dr. Alice Chu, Director of Market Access, Asia Pacific, Glaukos Corporation
- Sirinthip Petcharapiruch, Head of HEOR, Real-World Insights, IQVIA Asia Pacific
- Steve Conway, Regional Head of Health, Allianz Asia Pacific
- Moderator: Adrienne Mendenhall, Director, ACCESS Health International
7:00pm 7:30pm: Networking
Speakers' and Moderator's Profiles:
Dr. Alice Chu, Director of Market Access, Glaukos Corporation
Dr. Alice Chu is Director of Market Access, Asia-Pacific, for Glaukos Corporation, a U.S. ophthalmic medical technology company focused on the development and commercialization of products and procedures designed to transform the treatment of glaucoma, one of the world's leading causes of blindness. Her role focuses on improving patient access to the company's therapies based on clinical and economic evidence that demonstrate value for money to governments, payers, and hospital administrators. Prior to Glaukos, Alice was involved in health policy and market access efforts at Boston Scientific and Johnson & Johnson Medical both at the Southeast Asian and regional levels. She has worked in a variety of healthcare-related enterprises in the United States, such as medical communications and healthcare investments. Alice holds a doctorate degree in Molecular and Biochemical Nutrition from University of California, Berkeley and has published her scientific findings in leading journals. She also holds a master's degree in business administration from Singapore Management University. She is currently obtaining a master of public health degree at University of California, Berkeley, following her passion in health policy and education.
Sirinthip Petcharapiruch, Head of HEOR, Real-World Insights, IQVIA Asia Pacific
Sirinthip is the HEOR Lead at IQVIA Asia Pacific in the Real-World Insights team based out of Singapore. She is directly responsible and the subject matter expert for HEOR, HTA, pricing and market access strategy related consulting engagements in the region.
With over 9 years of extensive experience in roles focusing on generating HEOR evidence to support product strategy and HTA submissions, her areas of expertise lies in developing pricing and market access strategies, aligning data to evidence requirements in HTA market, and usage of evidence for pricing and reimbursement negotiations in Asia-Pacific market.
Sirinthip is a pharmacist by training and she holds a Master degree in Healthcare Research from Queen Mary, University of London, and a Postgraduate certificate in International HTA, Pricing and Reimbursement from University of Sheffield.
Steve Conway, Regional Head of Health, Allianz Asia Pacific
In his role at Allianz, Steve is responsible for providing portfolio management of US$350 Million of health business through Allianz entities in China, Taiwan, Philippines, Malaysia, Thailand, Laos, Sri Lanka and Indonesia.
Adrienne Mendenhall, Director, ACCESS Health International
Adrienne focuses on business development and building our Singapore network. She creates innovative partnerships across public and private sectors that result in new healthcare and aged care models. Adrienne developed the Modern Aging program in Singapore and continues to manage key accounts for the team.
Prior to joining ACCESS Health International, Adrienne worked in education administration for the National University of Singapore Saw Swee Hock School of Public Health. In the US, she had a decade of experience in community health promotion, focusing on reproductive and adolescent health and the prevention and management of noncommunicable chronic diseases. Adrienne received her Master's of Public Health from the University of Minnesota.
